Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it

Medications known as GLP-1s, which are prescribed for managing obesity and Type 2 diabetes, are increasingly common. However, a recent observation indicates that a majority of patients who start these drugs ultimately discontinue them. This trend is often accompanied by patients' plans to resume the medication at a future date.The practice of stopping and restarting GLP-1 drugs raises questions about potential health impacts. As of now, scientific research has not thoroughly investigated the long-term effects or safety of this on-again, off-again usage pattern. Patients considering such a cycle are advised to consult with their healthcare providers to understand the current knowledge and potential risks.